Bong-sook Baek

Array ( [id] => 9345092 [patent_doc_number] => 08664239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Tacrolimus for improved treatment of transplant patients' [patent_app_type] => utility [patent_app_number] => 13/167420 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38052 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561826 [patent_doc_number] => 20110275659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Tacrolimus For Improved Treatment Of Transplant Patients' [patent_app_type] => utility [patent_app_number] => 13/167381 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275659.pdf [firstpage_image] =>[orig_patent_app_number] => 13167381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670117 [patent_doc_number] => 20110319386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION' [patent_app_type] => utility [patent_app_number] => 13/157721 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 51132 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13157721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976101 [patent_doc_number] => 20130209531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'APPLICATIONS OF PARTIALLY AND FULLY SULFATED HYALURONAN' [patent_app_type] => utility [patent_app_number] => 13/702384 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10657 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311895 [patent_doc_number] => 08653113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Fungicidal composition and method for controlling plant diseases' [patent_app_type] => utility [patent_app_number] => 13/116640 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22108 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220900 [patent_doc_number] => 20120135088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'FUNGICIDAL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASES' [patent_app_type] => utility [patent_app_number] => 13/116615 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22107 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046892 [patent_doc_number] => 08541446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => '(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/116080 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 24113 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690210 [patent_doc_number] => 08389739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-05 [patent_title] => 'Modulators of retinoid-related orphan receptor gamma' [patent_app_type] => utility [patent_app_number] => 13/114616 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 40 [patent_no_of_words] => 27642 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016872 [patent_doc_number] => 20110224239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Combinations Comprising a S1P Receptor Agonist and a JAK3 Kinase Inhibitor' [patent_app_type] => utility [patent_app_number] => 13/112763 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8803 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224239.pdf [firstpage_image] =>[orig_patent_app_number] => 13112763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663778 [patent_doc_number] => 20110313047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'DELIVERY SYSTEM FOR HIGH CONCENTRATION OF CERAMIDE' [patent_app_type] => utility [patent_app_number] => 13/112021 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1330 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313047.pdf [firstpage_image] =>[orig_patent_app_number] => 13112021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15068297 [patent_doc_number] => 10463614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Butylphthalide intravenous emulsion and application thereof [patent_app_type] => utility [patent_app_number] => 13/112180 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3424 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090857 [patent_doc_number] => 20110218244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'CREATINE ß-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 13/108896 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6119 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218244.pdf [firstpage_image] =>[orig_patent_app_number] => 13108896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579655 [patent_doc_number] => 20110293538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'USE OF RUBUSOSIDE FOR REDUCING OR SUPPRESSING CERTAIN UNPLEASANT TASTE IMPRESSIONS' [patent_app_type] => utility [patent_app_number] => 13/104511 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14219 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293538.pdf [firstpage_image] =>[orig_patent_app_number] => 13104511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561770 [patent_doc_number] => 20110275603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/101921 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31654 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275603.pdf [firstpage_image] =>[orig_patent_app_number] => 13101921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574185 [patent_doc_number] => 20110269841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'THIN FILM WITH METHADONE ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/100232 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2217 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269841.pdf [firstpage_image] =>[orig_patent_app_number] => 13100232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574181 [patent_doc_number] => 20110269837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'PHOSPHORUS BINDER COMPOSITION FOR TREATMENT OF HYPERPHOSPHATEMIA' [patent_app_type] => utility [patent_app_number] => 13/097141 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8049 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269837.pdf [firstpage_image] =>[orig_patent_app_number] => 13097141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574173 [patent_doc_number] => 20110269829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 13/098031 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7358 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269829.pdf [firstpage_image] =>[orig_patent_app_number] => 13098031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567047 [patent_doc_number] => 20110287110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'COMBINATION CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/092341 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11705 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287110.pdf [firstpage_image] =>[orig_patent_app_number] => 13092341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311915 [patent_doc_number] => 08653133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Crystalline ingenol mebutate' [patent_app_type] => utility [patent_app_number] => 13/088910 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7109 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141013 [patent_doc_number] => 20120095059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Compositions and Methods for Treating Type II Diabetes and Related Disorders' [patent_app_type] => utility [patent_app_number] => 13/086213 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14736 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095059.pdf [firstpage_image] =>[orig_patent_app_number] => 13086213 [rel_patent_id] =>[rel_patent_doc_number] =>)